Thus, the absence or severe reduction of geranylgeranyl phosphate seen in patients with MKD results in lack of RhoA geranylation which keeps it “inactive/paralyzed” and prevents the protective pyrin phosphorylation that would allow the protective binding of 14-3-3 (74). This evidence concerns the gene MEFV and mevalonic aciduria.